Boston Scientific Shares Slip as Major Indexes Advance
The stock closed lower as the S&P 500, Dow and Nasdaq rose, with Boston Scientific’s next earnings report due October 28.
Makkler Newsroom · Oct 3, 01:58 AM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $49.93 (+12.6%)
Prices may be delayed and are for informational purposes only - not investment advice.
The stock closed lower as the S&P 500, Dow and Nasdaq rose, with Boston Scientific’s next earnings report due October 28.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.